Vericiguat is primarily used in the treatment of chronic heart failure, particularly in patients who have experienced a recent worsening of their condition. It functions as a soluble guanylate cyclase (sGC) stimulator, which helps to enhance the signaling pathway that leads to vasodilation and reduced cardiac strain. By improving the heart's ability to pump blood efficiently, it alleviates symptoms such as shortness of breath, fatigue, and fluid retention. This medication is often prescribed as part of a comprehensive treatment plan that includes other heart failure therapies to improve overall patient outcomes and reduce the risk of hospitalization.